ELYM: Eliem Therapeutics, Inc. Bozor kapitallashuvining daromadga nisbati
Eliem Therapeutics o'z strategiyasini depressiya va og'riq uchun xavfsiz terapiyalarni qidirishga asoslaydi. GURU.Markets grafigidagi sotuvlarga nisbatan narx ko'rsatkichi yon tomonga yo'naltirilgan tendentsiyani namoyish etmoqda, bunda yakuniy daraja belgisi vazifasini o'taydi. Bu neyrodorilarni ishlab chiqish bo'yicha ilmiy markazlar bilan hamkorlikni va aktivlar yangilanganidan so'ng neyroimmunologiya segmentidagi loyihalar portfelini kengaytirishni qo'llab-quvvatlaydi.
eliemtx.com (ELYM) kompaniyasi koʻrsatkichlari kesimi va tahlili
- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Eliem Therapeutics|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Eliem Therapeutics Inc.|ELYM - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Eliem Therapeutics Inc.|ELYM - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Eliem Therapeutics|Oraliq likvidlik koeffitsiyenti eliemtx.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
ELYM - Sof foyda|Kompaniya foydasi prognozi Eliem Therapeutics|ELYM - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Eliem Therapeutics, Inc.|ELYM - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Eliem Therapeutics Inc.|ELYM - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Eliem Therapeutics|ELYM - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi eliemtx.com|ELYM - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Eliem Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ELYM - eliemtx.com
P/S koeffitsienti Eliem Therapeutics (ELYM) bozor qiymatini uning operatsion daromadlari bilan solishtirib, daromadning har bir birligining investorlar nazaridagi qiymatini belgilaydi. Nevrologik dori vositalari uchun tartibga soluvchi organlarning tasdiqlashlariga bog'liq bo'lgan biotexnologiya sektori uchun sotuvlarga nisbatan narx koeffitsiyentidagi o'zgarishlar spekulyativ kutishlarning ko'rsatkichi bo'lib xizmat qiladi va bu fundamental biznes o'sishini aksiyalar narxiga bozor kayfiyatining vaqtincha ta'siridan ajratish imkonini beradi.
Eliem Therapeutics kimlar bilan raqobatlashadi
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Cassava Sciences|P/S multiplikatori ASRT (Assertio Holdings)|COYA - Kapitalizatsiyaning daromadga nisbati|vistagen.com - P/S multiplikatori|OVID: Narxning daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning daromadga nisbati|CervoMed Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc)|P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiya va daromad nisbati|KLTO: P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - P/S multiplikatori|Narxning daromadga nisbati Reviva Pharmaceuticals, Inc.|Kapitalizatsiyaning daromadga nisbati metaviatx.com (MTVA)|P/S multiplikatori NRXS|HSDT - Sotuvga nisbatan narx|Passage Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|bionomics.com.au (NEUP) - Sotuvga nisbatan narx|Minerva - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ATHA (Athira Pharma Inc)|ADXN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - P/S multiplikatori|PTIX (Protagenic Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori KTTA|Narx/daromad koeffitsiyenti Cortigent|P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning daromadga nisbati|Cara Therapeutics Inc. - P/S multiplikatori|Chromocell Therapeutics (CHRO) - Kapitalizatsiyaning daromadga nisbati|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati
